Cynthia J Galloway

Title: Cynthia J Galloway: Innovator in Microbial Inactivation Technologies

Introduction

Cynthia J Galloway is a prominent inventor based in Garner, NC (US). She has made significant contributions to the field of microbial inactivation technologies, holding a total of 3 patents. Her work focuses on methods that ensure the safety and efficacy of biological fluids.

Latest Patents

One of her latest patents is titled "Method of inactivating microorganisms in a fluid using ultraviolet radiation." This innovative method involves providing a UV reactor that includes an elongated generally annular reaction chamber surrounding at least one elongated UV lamp. The process moves the fluid within the reaction chamber in a primary flow directed along the length of the UV lamp while inducing a circulating secondary flow. This approach allows for uniform and controllable exposure of the entire volume of fluid to ultraviolet radiation, effectively inactivating microorganisms such as viruses while preserving desirable components like proteins.

Another notable patent is "Selective stabilization of protein during viral inactivation." This process involves contacting a solution containing a biologically active protein with an immobilized ligand, allowing the protein to bind to the ligand. The bound protein is then subjected to a viral inactivation method that would typically denature the protein if it were not bound. The recovery of the protein is achieved by washing the immobilized protein under conditions that favor the release of the protein while retaining its biological activity.

Career Highlights

Cynthia has worked with reputable organizations such as Bayer Corporation and Bayer Healthcare LLC. Her experience in these companies has contributed to her expertise in developing innovative solutions for microbial inactivation.

Collaborations

Throughout her career, Cynthia has collaborated with notable professionals in her field, including Klaus Kaiser and Hans-Juergen Henzler. These collaborations have further enhanced her research and development efforts.

Conclusion

Cynthia J Galloway is a trailblazer in the field of microbial inactivation technologies, with a focus on preserving biological activity while ensuring safety. Her innovative patents and career achievements reflect her dedication to advancing scientific knowledge and practical applications in this critical area.